248 related articles for article (PubMed ID: 34991831)
21. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
22. Predicting the Recurrence of Gastric Cancer Using the Textural Features of Perigastric Adipose Tissue on [
Ahn H; Song GJ; Jang SH; Son MW; Lee HJ; Lee MS; Lee JH; Oh MH; Jeong GC; Yun JH; Lee SM; Lee JW
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233285
[TBL] [Abstract][Full Text] [Related]
23. Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
Yoon HJ; Kang KW; Chun IK; Cho N; Im SA; Jeong S; Lee S; Jung KC; Lee YS; Jeong JM; Lee DS; Chung JK; Moon WK
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1534-43. PubMed ID: 24652232
[TBL] [Abstract][Full Text] [Related]
24. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
[TBL] [Abstract][Full Text] [Related]
25. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of primary tumor SUV
Yoo J; Yoon HJ; Kim BS
Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144
[TBL] [Abstract][Full Text] [Related]
27. Role of Textural Analysis of Pretreatment
Mishra A; Ravina M; Kote R; Kumar A; Kashyap Y; Dasgupta S; Reddy M
Indian J Nucl Med; 2023; 38(3):255-263. PubMed ID: 38046976
[TBL] [Abstract][Full Text] [Related]
28. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
[TBL] [Abstract][Full Text] [Related]
29. Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
Koo HR; Park JS; Kang KW; Han W; Park IA; Moon WK
Eur Radiol; 2015 Nov; 25(11):3314-21. PubMed ID: 25903708
[TBL] [Abstract][Full Text] [Related]
30. Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
Ekmekcioglu O; Aliyev A; Yilmaz S; Arslan E; Kaya R; Kocael P; Erkan ME; Halac M; Sonmezoglu K
Nucl Med Commun; 2013 Nov; 34(11):1055-67. PubMed ID: 24025919
[TBL] [Abstract][Full Text] [Related]
31. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
32. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
Arslan E; Çermik TF; Trabulus FDC; Talu ECK; Başaran Ş
Nucl Med Commun; 2018 Jul; 39(7):680-690. PubMed ID: 29893750
[TBL] [Abstract][Full Text] [Related]
33. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
[TBL] [Abstract][Full Text] [Related]
34. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of pretreatment
Han S; Lee SB; Gong G; Lee J; Chae SY; Oh JS; Moon DH
Breast Cancer Res Treat; 2023 Apr; 198(2):207-215. PubMed ID: 36633721
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.
Amrane K; Thuillier P; Bourhis D; Le Meur C; Quere C; Leclere JC; Ferec M; Jestin-Le Tallec V; Doucet L; Alemany P; Salaun PY; Metges JP; Schick U; Abgral R
Sci Rep; 2023 Apr; 13(1):5789. PubMed ID: 37031233
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral heterogeneity in
Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
40. 18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes.
Ozkan EE; Sengul SS; Erdogan M; Gurdal O; Eroglu HE
Nucl Med Commun; 2019 Oct; 40(10):1043-1050. PubMed ID: 31425343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
